Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01765660
What this trial is testing

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Nanfang Hospital, Southern Medical University 60
Early research (Phase 1)Study completedNCT05873907
What this trial is testing

Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AMG 592 in Healthy Participants

Who this might be right for
Chronic Graft-versus-host Disease (cGVHD)
Amgen 64
Not applicableStudy completedNCT01036958
What this trial is testing

Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-Versus-Host-Disease
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Ended earlyNCT01226420
What this trial is testing

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 6
Early research (Phase 1)Study completedNCT01810718
What this trial is testing

Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft Versus Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 22
Not applicableActive Not RecruitingNCT04431479
What this trial is testing

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 211
Not applicableStudy completedNCT02991846
What this trial is testing

A Prospective Observational Study for Evaluating CGVHD

Who this might be right for
Chronic Graft-Versus-Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 248
Testing effectiveness (Phase 2)Ended earlyNCT04111497
What this trial is testing

Glasdegib for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host DiseaseFasciitis
Fred Hutchinson Cancer Center 15
Testing effectiveness (Phase 2)WithdrawnNCT00004878
What this trial is testing

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Not applicableNo Longer AvailableNCT01200017
What this trial is testing

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more
Christopher Dvorak
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Very early researchActive Not RecruitingNCT03910452
What this trial is testing

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT02340676
What this trial is testing

A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT01318330
What this trial is testing

Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
Graft-vs-Host Disease
HomeoTherapy Co., Ltd 10
Not applicableLooking for participantsNCT05919511
What this trial is testing

Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Who this might be right for
cGVHD
Incyte Corporation 1,500
Large-scale testing (Phase 3)Study completedNCT00004255
What this trial is testing

Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Chimeric Therapies
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Large-scale testing (Phase 3)Ended earlyNCT01749111
What this trial is testing

Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoid LeukemiaMyeloproliferative Disease+3 more
Hospital Israelita Albert Einstein 3
Testing effectiveness (Phase 2)WithdrawnNCT05567406
What this trial is testing

Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

Who this might be right for
Chronic Graft Versus Host Disease
Kadmon, a Sanofi Company
Next Page